The DOI matches its Crossref record.
Estrogen, A Double-Edged Sword: Modulation of TH1- and TH2-Mediated Inflammations by Differential Regulation of TH1 / TH2 Cytokine Production
Abstract
Estrogen appears to play a central role in the immune response and immune-mediated diseases. Estrogen receptors are expressed in a variety of immunocompetent cells, including CD4(+) and CD8(+) T cells and macrophages. Clinical observations indicate that some autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, frequently remit during pregnancy but exacerbate, or have their onset during the postpartum period. Pharmacological levels of estrogen also appear to ameliorate certain autoimmune diseases. In addition, estrogen is known to suppress certain infectious diseases, as well as T cell-mediated responses toward oxazolone, keyhol lympet hemocyanin, Listeria soluble protein and purified protein derivatives. The immune basis for these phenomena is poorly understood. Based on a distinctive profile of cytokine production, data accumulated thus far have revealed modulatory effects for estrogen on the TH1-type and TH2-type cells, which represent two polarized forms of the effector specific immune response. Recent evidence indicates that estrogens inhibit the production of TH1 proinflammatory cytokines, such as IL-12, TNF-alpha and IFN-gamma, whereas they stimulate the production of TH2 anti-inflammatory cytokines, such as IL-10, IL-4, and TGF-beta. This can explain why estrogen suppresses and potentiates TH1- and TH2-mediated diseases, respectively. We hypothesize that exacerbation or suppression of inflammatory diseases by estrogen is mediated by skewing TH1-type to TH2-type response. This view represents a novel mechanism for the modulatory effect of estrogen on certain inflammatory diseases that can lead to beneficial or detrimental impacts depending on the type of immune involved. Such a concept is valuable when considering the application of combination therapies that include estrogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Challis, J. R., Lockwood, C. J., Myatt, L., Norman, J. E., Strauss, J. F., & Petraglia, F. (2009) · Reproductive Sciences · doi:10.1177/1933719108329095 · Cited by 893
Immunomodulatory and therapeutic properties of the Nigella sativa L. seed
Salem, M. L. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.06.008 · Cited by 853
Self-citationSugiyama, D., Nishimura, K., Tamaki, K., Tsuji, G., Nakazawa, T., Morinobu, A., & Kumagai, S. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096487 · Cited by 667
Understanding the vertebrate immune system: insights from the reptilian perspective
Zimmerman, L. M., Vogel, L. A., & Bowden, R. M. (2010) · Journal of Experimental Biology · doi:10.1242/jeb.038315 · Cited by 435
Oestrogen receptor negative breast cancers exhibit high cytokine content
Chavey, C., Bibeau, F., Gourgou-Bourgade, S., Burlinchon, S., Boissière, F., Laune, D., Roques, S., & Lazennec, G. (2007) · Breast Cancer Research · doi:10.1186/bcr1648 · Cited by 349
Estrogen Receptors in Immunity and Autoimmunity
Cunningham, M., & Gilkeson, G. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8203-5 · Cited by 291
Alternatively activated macrophages in infection and autoimmunity
Fairweather, D., & Cihakova, D. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.012 · Cited by 290
Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan
Desai, M. K., & Brinton, R. D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00265 · Cited by 273
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Extra-gonadal sites of estrogen biosynthesis and function
Barakat, R., Oakley, O., Kim, H., Jin, J., & Ko, C. J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.9.141 · Cited by 215
“In addition to the inhibitory effect on lymphopoiesis, estradiol has been shown to influence T helper (Th) responses; inhibit the production of Th1 cytokines such as IL-12, TNF-, and IFN-; and stimulate Th2 anti-inflammatory cytokine production such as IL-10, IL-4, and TGF- (94).”
BackgroundMartino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
Pepe, G., Braga, D., Renzi, T. A., Villa, A., Bolego, C., D’Avila, F., Barlassina, C., Maggi, A., Locati, M., & Vegeto, E. (2017) · Scientific Reports · doi:10.1038/srep44270 · Cited by 80
de Oliveira, A. P. L., Domingos, H. V., Cavriani, G., Damazo, A. S., dos Santos Franco, A. L., Oliani, S. M., Oliveira-Filho, R. M., Vargaftig, B. B., & de Lima, W. T. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00286.2006 · Cited by 79
“Interestingly, recent evidence has indi- cated that estradiol stimulates the production of Th2-derived anti-inflammatory cytokines such as IL-10, IL-4, and TGF(32), which might explain the observed profile of pulmonary inflammation in Ovx-allergic rats.”
HPV related VIN: highly proliferative and diminished responsiveness to extracellular signals
Santegoets, L. A. M., Seters, M. V., Helmerhorst, T. J. M., Heijmans‐Antonissen, C., Hanifi‐Moghaddam, P., Ewing, P. C., van IJcken, W. F. J., van der Spek, P. J., van der Meijden, W. I., & Blok, L. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22769 · Cited by 40
Roomruangwong, C., Sirivichayakul, S., Carvalho, A. F., & Maes, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.033 · Cited by 29
Casanova, E., Sharp, J., Edelson, S., Kelly, D., & Casanova, M. (2018) · Behavioral Sciences · doi:10.3390/bs8030035 · Cited by 18
“Estrogen also stimulates mast cell degranulation, prompting a release of chemicals such as histamines, TNF-α, various amines, chymase, and tryptase [74,75].”
Background
Metadata
- Authors
- Salem, M.
- Venue
- Current Drug Target -Inflammation & Allergy
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-03-01
- Volume
- 3
- Issue
- 1
- Pages
- 97-104
- ISSN
- 1568-010X (ISSN-L)
- OpenAlex
- W2030480043
- Cited by
- 288
- References
- 0
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.